Veracyte to Present Practice-Changing Oncology Data at ASCO 2026 Highlighting Advances in Breast and Prostate Cancer Genomic Testing Veracyte announced that major new clinical data involving its Prosigna Breast and Decipher Prostate genomic tests will be presented during the 2026…
InSphero AG has acquired PhenoVista Biosciences, Inc. to strengthen its advanced 3D cell-based assay capabilities and expand translational research solutions. InSphero AG has announced the acquisition of PhenoVista Biosciences, Inc., a strategic move aimed at expanding capabilities in advanced drug…
CONMED Corporation has appointed Celine Martin and Jeff Mirviss to its Board of Directors, strengthening the company’s leadership and strategic expertise. CONMED Corporation has announced the appointment of two seasoned healthcare industry leaders, Celine Martin and Jeff Mirviss, to its…
Cosette Pharmaceuticals Enhances Commercial Leadership With Addition of Industry Veteran David Bell Cosette Pharmaceuticals has announced the appointment of David Bell as Chief Commercial Officer for its branded business, marking another step in the company’s ongoing effort to strengthen its…
Sustained Therapeutics Highlights Positive Mid-Stage Clinical Outcomes for Its Investigational Therapy ST-01 Sustained Therapeutics has reported additional positive findings from its Phase 2 clinical study evaluating ST-01, the company’s proprietary non-opioid sustained-release therapy for men suffering from chronic scrotal content…
Sumitomo Pharma America Presents AUA 2026 Data Showing Vibegron Benefits in Older Men With Overactive Bladder and BPH Sumitomo Pharma America presented new clinical and real-world evidence from its urology and oncology portfolios at the American Urological Association 2026 Annual…
Orca Bio Names Bijan Nejadnik as Chief Medical Officer Orca Bio has announced a major leadership transition as the company continues advancing toward commercialization of its high-precision cell therapy platform. The company appointed Bijan Nejadnik as its new Chief Medical…
Target RWE and NoviSci Rebrand as Pedestal Health and Headwater Science Target RWE and NoviSci have announced a major rebranding initiative as the two organizations position themselves to reshape how evidence is generated and applied across the life sciences industry.…
Parabilis Medicines Partners With Regeneron Pharmaceuticals to Develop Antibody-Helicon™ Conjugates Across Multiple Diseases Parabilis Medicines has entered into a major strategic research collaboration with Regeneron Pharmaceuticals aimed at advancing a new generation of targeted medicines designed to tackle some of…
Genentech Receives FDA Approval for Tecentriq in ctDNA-Guided Treatment of Muscle-Invasive Bladder Cancer Genentech announced that the U.S. Food and Drug Administration has approved both Tecentriq and Tecentriq Hybreza as adjuvant treatments for adult patients with muscle-invasive bladder cancer (MIBC)…
ICUS Supports New Sonography Training Standards Expanding Education in Contrast Enhanced Ultrasound International Contrast Ultrasound Society has expressed strong support for newly proposed accreditation standards that could significantly expand education and training in contrast enhanced ultrasound (CEUS) for future sonographers…
Glooko Receives FDA 510(k) Clearance for EndoTool IV Cloud Platform Glooko, Inc., a global digital health company specializing in diabetes management and glycemic safety solutions, has announced that the U.S. Food and Drug Administration has granted 510(k) clearance for EndoTool…